AI summary

Retatrutide batch [NAME_REDACTED] tested at 99.81% purity by third-party lab (Janoshik) on 09 JUN 2026. Blind peptide identification confirmed compound identity; no endotoxin or fill-weight data provided.

Test date
2026-06-09
Purity
99.81% 99.810%
Batch / lot
[NAME_REDACTED]
Lab
FSD
Quantity
labeltested 33.66mg
Qty vs label
Endotoxins
Test score
Manufacturer
FSD
View vendor dossier
Peptides on this report
Retatrutide Semaglutide Tirzepatide
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Community submission

✓ Artifact captured

We have the certificate image — you can verify it loads from the upstream lab and matches the artifact below.

Catalogued
2026-06-14
OCR text

Raw extracted text

Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display.

TEST REPORT JANOSHIK E-mail: [EMAIL_REDACTED] Web: www.janoshik.com Task Number #167469 Testing ordered > 25 MAY '26 Sample received > 02 JUN '26 Client Dead Lurker Test Group Sample R30 Manufacturer FSD Batch FSD0706 Sample description > See picture or pictures attached. Tests requested > [NAME_REDACTED] peptide blind test (Semaglutide, Tirzepatide and Retatrutide) Results > Retatrutide 33.66 mg Purity 99.810% Comments > Analysis conducted > 09 JUN 2026 Signature > Verify this test at www.janoshik.com/verify/ with the following unique key ISN795DVEIPM
This COA is part of TitrateLab's community-trust corpus. See more from FSD or learn how trust scores are computed on the methodology page.